Jane Street Group, LLC Eye Point Pharmaceuticals, Inc. Call Options Transaction History
Jane Street Group, LLC
- $384 Billion
- Q1 2025
Call Options
2 transactions
Others Institutions Holding EYPT
# of Institutions
164Shares Held
71.6MCall Options Held
232KPut Options Held
207K-
Cormorant Asset Management, LP Boston, MA8.33MShares$50.5 Million4.79% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$41.3 Million1.61% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.2MShares$37.6 Million0.07% of portfolio
-
Franklin Resources Inc San Mateo, CA4.15MShares$25.2 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.09MShares$24.8 Million0.05% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $207M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...